Everest Medicines Company
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Technology:
Biotechnology, Health Care, Pharmaceutical
Industry:
Clinical Development
Headquarters:
New York, New York, United States
Founded Date:
2017-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
10
Total Funding:
310000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-06-03
Last Funding Type:
Series C
Register and Claim Ownership